Item 2.02 Results of Operations and Financial Condition
On
A copy of the presentation that will be used during the conference call
presenting the Company's financial results for the quarter ended
The information included in this Current Report on Form 8-K (including Exhibits 99.1 and 99.2 hereto) that is furnished pursuant to this Item 2.02 shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. In addition, the information included in this Current Report on Form 8-K (including Exhibits 99.1 and 99.2 hereto) that is furnished pursuant to this Item 2.02 shall not be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference into such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits No. Description 99.1 Press Release ofAltimmune, Inc. datedMay 17, 2021 99.2 Presentation ofAltimmune, Inc. datedMay 17, 2021
--------------------------------------------------------------------------------
© Edgar Online, source